Nirsevimab 50MG PFS 5S
Ended Awarded Last action
- Contract number
- SPE2DR26FASEV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,316
Award facts
- Contract value 100% obligated
- $43,315.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $43,315.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Nirsevimab 50mg pre-filled syringes (5-count units). This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 3, 2025. Nirsevimab is a monoclonal antibody immunization for respiratory syncytial virus (RSV) prevention in infants and young children, indicating this procurement supports the military healthcare system's immunization requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp serves the Defense Health Agency and other military healthcare systems through this comprehensive global pharmaceutical support vehicle, which enables flexible ordering of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FASEV?
SPE2DR26FASEV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FASEV worth?
The government has obligated $43,316 on SPE2DR26FASEV.
Is contract SPE2DR26FASEV an order under another contract?
Yes. SPE2DR26FASEV is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FASEV competed?
The extent of competition for SPE2DR26FASEV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award